Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet before FDG-PET/CT for Evaluation of Patients with Suspected Cardiac Sarcoidosis

Clinical Nuclear Medicine

Volumn 42, Issue 2, 2017, Pages 88-94

  Lu, Yang ^a   Grant, Christopher ^a   Xie, Karen ^a   Sweiss, Nadera J ^a  

^a UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

Author keywords

cardiac imaging; cardiac sarcoidosis; FDG; patient preparation protocol; PET CT

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; HYDROXYCHLOROQUINE; INFLIXIMAB; INSULIN; LEFLUNOMIDE; METHOTREXATE; STEROID; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BLOOD FLOW; CARDIAC MUSCLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONSENSUS; CONTROLLED STUDY; DRUG UPTAKE; ECG ABNORMALITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART PALPITATION; HUMAN; HUMAN TISSUE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIPID DIET; LIVER; LOW CARBOHYDRATE DIET; MAJOR CLINICAL STUDY; MALE; MEDIASTINAL BLOOD POOL; MEDIASTINUM; MYOCARDIAL UPTAKE; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROTEIN DIET; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; SARCOIDOSIS; STANDARDIZED UPTAKE VALUE MAX; THORAX PAIN; CARDIOMYOPATHY; DIAGNOSTIC IMAGING; METABOLISM; MIDDLE AGED; PROCEDURES;

ADULT; AGED; CARDIOMYOPATHIES; DIET, CARBOHYDRATE-RESTRICTED; DIET, HIGH-FAT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SARCOIDOSIS;

EID: 85002293083     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000001465     Document Type: Article

References (28)

1. Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014;383:1155-1167.
2. Sharma OP,Maheshwari A, Thaker K.Myocardial sarcoidosis. Chest. 1993; 103:253-258.
3. Albert CM, Chae CU, Grodstein F, et al. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107: 2096-2101.
4. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2007;28:3076-3093.
5. Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol. 2009;20:578-583.
6. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969-1977.
7. Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J NuclMed. 2012;53:241-248.
8. Schatka I, Bengel FM. Advanced imaging of cardiac sarcoidosis. J Nucl Med. 2014;55:99-106.
9. Ohira H, Tsujino I, Ishimaru S, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2008;35:933-941.
10. Ishida Y, Yoshinaga K, Miyagawa M, et al. Recommendations for (18)Ffluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med. 2014;28:393-403.
11. Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol. 2008;190:W151-W156.
12. Langah R, Spicer K, Gebregziabher M, et al. Effectiveness of prolonged fasting 18F-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol. 2009;16:801-810.
13. Harisankar CN,Mittal BR, Agrawal KL, et al. Utility of high fat and low carbohydrate diet in suppressingmyocardial FDGuptake. J Nucl Cardiol. 2011; 18:926-936.
14. Morooka M, Moroi M, Uno K, et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res. 2014;4:1.
15. OkumuraW, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 2004;45:1989-1998.
16. Soussan M, Brillet PY, Nunes H, et al. Clinical value of a high-fat and lowcarbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20:120-127.
17. Randle PJ, Garland PB, Hales CN, et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
18. Ito K, Okazaki O, Morooka M, et al. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis. Intern Med. 2014;53:2041-2049.
19. Lu Y, Sweiss NJ. MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis. Clin Nucl Med. 2015;40:973-974.
20. Miller CT, Sweiss NJ, Lu Y. FDG PET/CTevidence of effective treatment of cardiac sarcoidosis with adalimumab. Clin Nucl Med. 2016;41:417-418.
21. Wisneski JA, Gertz EW, Neese RA, et al. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J Clin Invest. 1987;79:359-366.
22. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med. 1990;31:1749-1756.
23. Persson E. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin). Acta Med Scand Suppl. 1988;724:1-56.
24. Nuutila P, Koivisto VA, Knuuti J, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest. 1992;89:1767-1774.
25. Ishii A, Hoshii Y, Nakashima T, et al. Sarcoidosis with pulmonary hypertension exacerbated by Takayasu-like large vessel vasculitis. Pathol Int. 2011; 61:546-550.
26. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J. 2005;26:1538-1543.
27. Wykrzykowska J, Lehman S,WilliamsG, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med. 2009;50:563-568.
28. Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63:329-336.